SYNTHESIS OF PHENYL HYDRAZINE SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR BIOLOGICAL ACTIVITYHTML Full Text
SYNTHESIS OF PHENYL HYDRAZINE SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR BIOLOGICAL ACTIVITY
VENKATARAMANA HS C.1, SINGH A.2, TIWARI A.1*, TIWARI V.1
Department of Pharmaceutical Chemistry, M. S. Ramaiah College of Pharmacy*1, Bangalore, Karnataka, India
Devsthali Vidyapeeth College of Pharmacy2, Lalpur, Rudrapur (U. S. Nagar), Uttrakhand, India
ABSTRACT: Condensation of o-phenylene diamine with chloro acetic acid gave 2-chloromethyl benzimdazole, which undergoes halide replacement with phenylhydrazines to give the corresponding NN' disubstituted hydrazines. The synthesized compounds were subjected to microbiological screening and In- vitro anti-inflammatory activity.
2-chloromethyl benzimidazole, phenyl hydrazine, antimicrobial activity
Benzimidazole derivatives are an important class of nitrogen containing heterocycles and were reported to possess a wide spectrum of biological properties such as antibacterial, analgesic, anti-inflammatory, antifungal and antimalarial activities. Although a number of drugs are available in the market, thirst for discovering new antimicrobial drugs with better pharmacokinetic profile, and lesser toxicity has become main objectives in the field of medicinal chemistry due to fast development of microbial resistance towards the existing molecules.
Despite a number of drugs being in clinical use, search for new NSAIDS is still relevant because the existing molecules suffer from the drawback of adverse effects such as gastric ulceration, inhibition of platelet function, alterations in the renal function, hypersensitivity reactions etc.
RESULTS AND DISCUSSION:
2- Chloro-methyl benz-imidazoles were prepared by Condensation of O-phenylene diamines with Chloroacetic acid. 2- [(2-phenyl-hydrazinyl) methyl] - 1H- benz-imidazole were prepared by the halide replacement of substituted 2- chloro-methyl benz-imidazole with Phenyl hydrazinyl ring.
- a) Antibacterial activity:
The antibacterial activity of newly synthesized benzimidazole derivatives has been evaluated against Gram positive Staphylococcus aureus and Enterobacter cocci and Gram negative Escherichia coli and Shigella species by disc diffusion method.
The standards used are Norfloxacin and Gatifloxacin. The antibacterial data is given in the Data- 1.
- b) Antifungal activity:
Aspergillus niger and Aspergillus flavus: The antifungal activity of newly synthesized benzimidazole derivatives have been evaluated against Aspergillus niger and Aspergillus flavus the standard used is Clotrimazole and Amphotericin B. The antifungal data is given in the Data- 2.
The observation of other compounds revealed that the substitution of 6-nitro group in benzimidazole ring increases the antibacterial activity. All compounds have shown antibacterial activity against Gram positive bacteria as well as gram negative bacteria namely Staphylococcus aureus, Enterococci and Escherichia coli Shigella (Gram negative). The 6-nitro derivative of benzimidazole shows good activity against Aspergillus niger and Aspergillus flavus..
Melting points of the synthesized compounds were determined by open capillary method and were uncorrected. IR spectral analysis was carried out using FTIR-8400S, SHIMADZU at M.S.Ramaiah College of Pharmacy, Bangalore. 1HNMR spectral data was obtained from Indian Institute of Sciences, Bangalore.
The instrument used was amx-400 and the solvent used was deuterated chloroform. The mass spectral data were recorded from LCMS 2010A, SHIMADZU provided by UWIN Global Services, Bangalore.
General procedure for preparation of phenyl hydrazines 3:
To a solution of Hydrazine hydrate (0.2mol, 10ml.), hydrochloric acid (10ml) was added dropwise in such a manner that the temperature of solution was maintained at 5-10º C, followed by ethylene glycol (40 ml) and then substituted aniline (0.087mol) was added. The mixture was refluxed for 2 hours, cooled to room temperature. The separated solid was filtered, dried and recrystallised from ethanol. The yields ranged from 50 – 65%.
General procedure for synthesis of substituted 2- (chloro- methyl)- 1H-benz-imidazole 4, 5, 6:
The o-phenylene diamine (0.01mol) was dissolved in 4N HCl and chloroacetic acid (0.01mol) was added. The mixture was refluxed for 4 hours, cooled and on neutralization with sodium bicarbonate, the product was precipitated. It was filtered, washed with water, dried and recrystalized from ethyl acetate or aqueous ethanol. The yields ranged from 30 –60 %. The spectral data is given below-
Data- 1: IR (KBr): 3249,3213 (N-H str), 1512 (N-H bend), 3056, 3008 (Ar ,C-H str ), 1469, 1443 (C=C str), 2950 (CH2 str), 819 (C-Cl) 1HNMR (MeOD): 3.5 (2H, CH2), 12.0 (1H, NH benzimidazole), 7.3 (2H Ar-benzimidazole), 7.6 (2H, Ar-benzimidazole). Mass: M/e-167 (M+), 169 (M+2) and other important peaks are 149, 119.
General procedure for synthesis of 2-[(2-phenylhydrazinyl) methyl} - 1H- benzimidazole7:
To the ethanolic solution of 2-Chloromethylbenzimidazoles (0.02mol) phenylhydrazine (0.0217mol) were added and it was refluxed for 5 hr. hot mixture was poured in crushed ice with constant stirring. Separated solid was filtered, dried, and recrystallized from ethanol. The yields ranged from 45-65 %. The spectral data is given below-
Data- 2: IR (KBr): 3487, 3404 (N-H str), 1510 (N-H bend), 3053 (Ar, C-H str), 2887, 2817 (CH2 str), 1469, 1436 (C=C str). 1HNMR (CDCl3): 3.6 (2H, CH2), 4. 2 (1H N-H hydrazinyl), 4.5 (1H N-H hydrazinyl), 12.0 (1H, NH Ar-benzimidazole), 8.3 (4H Ar-benzimidazole), 7.8 (5H, phenyl), Mass: M/e-237 (M+) and other important peaks are 124, 109.
The authors thank Mrs. R. Mythreyi, Assistant Professor, M. S. Ramaiah College of Pharmacy for her valuable suggestions during microbiological work. Their thanks are also due to M. S. Ramaiah Medical College for providing the cultures of micro-organisms, to Indian Institute of Sciences (IISc.), Bangalore, for the 1HNMR reports and to Quest, Bangalore, for the Mass spectral reports.
- Nagata K, Itoh T, Ishikawa H, Ohsawa A. Heterocycles 2003 August; 61: 93-96.
- Goudgaon NM, Dhondiba V, Vijayalaxmi A. Indian J Heterocycl Chem 2004 Jan-March; 13: 271-272.
- Jayachandran E, Naragund LVG, Shivakumar B, Bhatia K. Orient J Chem. 2003; 19(1): 139-142.
- Fang JF, Li BF, Xin W, De LL. Chinese J Struct Chem 2003; 22(4): 382-386.
- Bahrami K, Khodaei MM, Kavianinia J Che Res 2006 December: 783-784.
- Michael C, Assmann, Lutz, Wroblowsky, Jurgen H. United States Patent
- El-Emary TI. J Chin Chem Soc. 2006; 53: 391-401.
- Deshmukh MB, Jagtap SS, Deshmukh SA. J Indian Chem Soc 2006 Oct; 83: 1055-1057.
- Davis WW, Stout TR. Appl Microbiol 1971 Oct: 659-665.
- Elias G, Rao MNA. Indian J Exp Biol 1988 July; 26: 540-542.
VENKATARAMANA HS C., SINGH A., TIWARI A.*, TIWARI V.
Department of Pharmaceutical Chemistry, M. S. Ramaiah College of Pharmacy*, Bangalore, Karnataka, India
14 December, 2009
23 December, 2009
29 December, 2009
01 January, 2010